Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women
Yale University · with National Institute on Drug Abuse (NIDA) · NCT05547048
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 4
- Target enrollment
- 250
- US sites recruiting
- 2
- Study start
- July 25, 2023
- Record last updated
- June 3, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this 2-site (CT, AL) study is to test innovative interventions to reduce stigma and improve the pre-exposure prophylaxis (PrEP) and opioid use disorder (OUD) care continua in women involved in the criminal justice system (WICJ).
This study evaluates a newly validated PrEP decision aid and eHealth for integrated PrEP and MOUD compared to a decision aid-only for WICJ with OUD.
Being studied: Decision Aid; Athena strategy
Conditions: HIV; Opioid Use Disorder; eHealth
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- woman
- have access to a working mobile or landline phone
- Lifetime CJ-involvement (probation, parole, intensive pretrial or community supervision, or release from prison/jail)
- are confirmed HIV-negative by point-of-care 3rd generation HIV antibody test
- meet clinical criteria for PrEP
- have opioid use disorder (regardless of baseline treatment status)
Exclusion Criteria
- unable or unwilling to provide informed consent
- pregnant or breast-feeding
- currently taking PrEP at the time of study enrollment
- not comfortable conversing in English or Spanish.
Recruiting US locations
University of Alabama in Birmingham
Birmingham, AL 35294
Site contact: Ellen Eaton · 205-934-3411 · eeaton@uabmc.edu
Yale University
New Haven, CT 06519
Site contact: Carolina Price, MPA · 203-499-8075 · carolina.price@yale.edu
Study contacts (from the official record)
- Adrienne L Marable · (203) 737-3393 · gcat5@yale.edu
Similar studies in Alabama
All healthy volunteers studies in Alabama →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Birmingham, AL + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Gadsden, AL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Regeneron Pharmaceuticals
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)
Merck Sharp & Dohme LLC
- Location
- Anniston, AL
- Eligibility basics
- Ages 18–65